Burning Rock Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Burning Rock Biotech has a total shareholder equity of CN¥677.8M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.0B and CN¥345.5M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥532.54m |
| Equity | CN¥677.85m |
| Total liabilities | CN¥345.54m |
| Total assets | CN¥1.02b |
Recent financial health updates
Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?
Mar 25
Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?
Apr 28We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully
Dec 23Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?
Sep 20Recent updates
Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues
Jun 21Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?
Mar 25There's No Escaping Burning Rock Biotech Limited's (NASDAQ:BNR) Muted Revenues
Feb 01Burning Rock Biotech Limited (NASDAQ:BNR) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jul 12Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?
Apr 28We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully
Dec 23Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?
Sep 20Burning Rock Biotech GAAP EPS of -$0.37 misses by $0.01, revenue of $19.5M misses by $2.94M
Aug 31Burning Rock Localizes As Investors Grow Impatient
Jun 06We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely
Mar 24Following Rough Year, Is Burning Rock Set To Turn The Corner?
Nov 17Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?
Aug 27A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)
Jul 23Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?
May 13Burning Rock Biotech Expands Test Portfolio In Bid For Growth
Dec 30Burning Rock inks license pact with Oncocyte Corporation
Dec 15Burning Rock Biotech prices upsized offering of 2.243M ADSs at $25.75/ADS
Dec 04Burning Rock Biotech EPS misses by $0.08, beats on revenue
Nov 20Financial Position Analysis
Short Term Liabilities: BNR's short term assets (CN¥806.3M) exceed its short term liabilities (CN¥259.6M).
Long Term Liabilities: BNR's short term assets (CN¥806.3M) exceed its long term liabilities (CN¥85.9M).
Debt to Equity History and Analysis
Debt Level: BNR is debt free.
Reducing Debt: BNR has no debt compared to 5 years ago when its debt to equity ratio was 26.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BNR has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: BNR has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 12.3% each year.